Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
n decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
621
-
622
-
623
-
624
-
625
Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study
Published 2024“…In this investigation, the ignition delay times (IDTs) of NH<sub>3</sub>/<i>n</i>C<sub>16</sub>H<sub>34</sub> mixtures were measured in a rapid compression machine at different NH<sub>3</sub> energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”
-
626
Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study
Published 2024“…In this investigation, the ignition delay times (IDTs) of NH<sub>3</sub>/<i>n</i>C<sub>16</sub>H<sub>34</sub> mixtures were measured in a rapid compression machine at different NH<sub>3</sub> energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”
-
627
Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study
Published 2024“…In this investigation, the ignition delay times (IDTs) of NH<sub>3</sub>/<i>n</i>C<sub>16</sub>H<sub>34</sub> mixtures were measured in a rapid compression machine at different NH<sub>3</sub> energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”
-
628
Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study
Published 2024“…In this investigation, the ignition delay times (IDTs) of NH<sub>3</sub>/<i>n</i>C<sub>16</sub>H<sub>34</sub> mixtures were measured in a rapid compression machine at different NH<sub>3</sub> energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”
-
629
-
630
-
631
-
632
-
633
-
634
-
635
-
636
-
637
-
638
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Published 2022“…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”
-
639
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Published 2022“…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”
-
640
Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease
Published 2022“…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …”